Cell Publication Highlights Ionpath MIBI Spatial Proteomics Technology in Foundational Study Predicting Breast Cancer Progression

Source :: Business Wire. January 20, 2022
Publication Year :: 2022
Abstract: Innovative study deployed multiplexed ion beam imaging (MIBI[TM]) technology revealing a high-multiplex spatial proteomic signature as a predictive biomarker for breast cancer treatment MENLO PARK, Calif. -- Ionpath, Inc., the [...]

Subjects :: Ion bombardment -- Usage
Medical test kit industry -- Reports
Proteomics -- Usage
Medical equipment and supplies industry -- Reports
Universities and colleges -- Research -- United States
Breast cancer -- Diagnosis -- Care and treatment -- Development and progression
Diagnostic imaging -- Technology application
Technology application
Business
Business, international

Tools